Paclitaxel 33069-62-4
| Systematic (IUPAC) name: |
(2α,4α,5β,7β,10β,13α)-4,10-bis(acetyloxy)-13-{[(2R,3S)- 3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}- 1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate |
| Paclitaxel CAS number: |
33069-62-4 |
| ATC code: |
L01CD01 (paclitaxelpoliglumex) |
| PubChem: |
36314 |
| DrugBank: |
DB01229 |
| Formula: |
C47H51N1O14 |
| Molecular mass: |
853.906 g/mol |
| Paclitaxel Assay/Purity: |
Typically NLT 98% |
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
